Ultrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of art.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 193, doi. 10.2147/OV.S66097
- By:
- Publication type:
- Article
Works matching IS 22531572 AND DT 2015 AND VI 4
Results: 20
1
2
Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 183, doi. 10.2147/OV.S66081
- By:
- Publication type:
- Article
3
Oncolytic virotherapy using herpes simplex virus: how far have we come?
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 207, doi. 10.2147/OV.S66086
- By:
- Publication type:
- Article
4
Targeting tumor vasculature through oncolytic virotherapy: recent advances.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 169, doi. 10.2147/OV.S66045
- By:
- Publication type:
- Article
5
Oncolytic Sendai virus-based virotherapy for cancer: recent advances.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 141, doi. 10.2147/OV.S66419
- By:
- Publication type:
- Article
6
Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 157, doi. 10.2147/OV.S66079
- By:
- Publication type:
- Article
7
Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 149, doi. 10.2147/OV.S66010
- By:
- Publication type:
- Article
8
Characterization of an oncolytic adenovirus vector constructed to target the cMet receptor.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 119, doi. 10.2147/OV.S87369
- By:
- Publication type:
- Article
9
Oncolytic virotherapy for human malignant mesothelioma: recent advances.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 133, doi. 10.2147/OV.S66091
- By:
- Publication type:
- Article
10
On the potential of oncolytic virotherapy for the treatment of canine cancers.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 95, doi. 10.2147/OV.S66358
- By:
- Publication type:
- Article
11
Advances in the design and development of oncolytic measles viruses.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 109, doi. 10.2147/OV.S66078
- By:
- Publication type:
- Article
12
Oncolytic virotherapy for head and neck cancer: current research and future developments.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 83, doi. 10.2147/OV.S54503
- By:
- Publication type:
- Article
13
Promising oncolytic agents for metastatic breast cancer treatment.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 63, doi. 10.2147/OV.S63045
- By:
- Publication type:
- Article
14
Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 75, doi. 10.2147/OV.S54738
- By:
- Publication type:
- Article
15
Therapeutic potential of oncolytic Newcastle disease virus: a critical review.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 49, doi. 10.2147/OV.S78600
- By:
- Publication type:
- Article
16
Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 39, doi. 10.2147/OV.S54780
- By:
- Publication type:
- Article
17
Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor--resistant multiple myeloma.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 1, doi. 10.2147/OV.S72372
- By:
- Publication type:
- Article
18
Extended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapy.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
19
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594).
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 25, doi. 10.2147/OV.S59640
- By:
- Publication type:
- Article
20
The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 13, doi. 10.2147/OV.S45525
- By:
- Publication type:
- Article